Free Trial

Polyrizon (PLRZ) Competitors

Polyrizon logo
$1.07 +0.27 (+33.75%)
As of 04:00 PM Eastern

PLRZ vs. SNYR, JATT, ELEV, CING, DRRX, LGVN, LPCN, COCP, MRKR, and GOVX

Should you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include Synergy CHC Corp. (Uplisting) (SNYR), JATT Acquisition (JATT), Elevation Oncology (ELEV), Cingulate (CING), DURECT (DRRX), Longeveron (LGVN), Lipocine (LPCN), Cocrystal Pharma (COCP), Marker Therapeutics (MRKR), and GeoVax Labs (GOVX). These companies are all part of the "pharmaceutical products" industry.

Polyrizon vs. Its Competitors

Polyrizon (NASDAQ:PLRZ) and Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, community ranking, institutional ownership, profitability and media sentiment.

Synergy CHC Corp. (Uplisting) has a consensus target price of $10.00, suggesting a potential upside of 336.68%. Given Synergy CHC Corp. (Uplisting)'s stronger consensus rating and higher possible upside, analysts clearly believe Synergy CHC Corp. (Uplisting) is more favorable than Polyrizon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Polyrizon
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Synergy CHC Corp. (Uplisting)
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

In the previous week, Synergy CHC Corp. (Uplisting) had 7 more articles in the media than Polyrizon. MarketBeat recorded 9 mentions for Synergy CHC Corp. (Uplisting) and 2 mentions for Polyrizon. Polyrizon's average media sentiment score of 1.87 beat Synergy CHC Corp. (Uplisting)'s score of 0.94 indicating that Polyrizon is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Polyrizon
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Synergy CHC Corp. (Uplisting)
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company Net Margins Return on Equity Return on Assets
PolyrizonN/A N/A N/A
Synergy CHC Corp. (Uplisting) N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PolyrizonN/AN/AN/AN/AN/A
Synergy CHC Corp. (Uplisting)$33.59M0.63N/AN/AN/A

Synergy CHC Corp. (Uplisting) received 2 more outperform votes than Polyrizon when rated by MarketBeat users. Likewise, 66.67% of users gave Synergy CHC Corp. (Uplisting) an outperform vote while only 0.00% of users gave Polyrizon an outperform vote.

CompanyUnderperformOutperform
PolyrizonOutperform Votes
No Votes
Underperform Votes
2
100.00%
Synergy CHC Corp. (Uplisting)Outperform Votes
2
66.67%
Underperform Votes
1
33.33%

Summary

Synergy CHC Corp. (Uplisting) beats Polyrizon on 8 of the 9 factors compared between the two stocks.

Get Polyrizon News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PLRZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PLRZ vs. The Competition

MetricPolyrizonPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$5.70M$6.92B$5.61B$8.62B
Dividend YieldN/A2.55%5.28%4.17%
P/E RatioN/A8.6727.1419.96
Price / SalesN/A262.53411.83157.63
Price / CashN/A65.8538.2534.64
Price / BookN/A6.597.064.69
Net IncomeN/A$143.75M$3.23B$248.14M
7 Day Performance26.42%3.72%2.67%2.39%
1 Month Performance-98.78%11.01%8.82%6.05%
1 Year PerformanceN/A3.87%31.44%13.60%

Polyrizon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PLRZ
Polyrizon
N/A$1.07
+33.8%
N/AN/A$5.70MN/A0.00N/ANews Coverage
Positive News
Gap Up
High Trading Volume
SNYR
Synergy CHC Corp. (Uplisting)
3.825 of 5 stars
$2.04
-1.4%
$10.00
+390.2%
N/A$18.76M$33.59M0.0040News Coverage
JATT
JATT Acquisition
N/A$1.07
+5.9%
N/A-66.0%$18.46MN/A0.003High Trading Volume
ELEV
Elevation Oncology
3.4049 of 5 stars
$0.30
-0.2%
$3.39
+1,013.0%
-88.9%$18.02MN/A-0.3740Trending News
Analyst Downgrade
Short Interest ↓
Analyst Revision
CING
Cingulate
1.9721 of 5 stars
$4.24
+6.5%
$26.00
+513.2%
+552.1%$18.00MN/A-0.5020Short Interest ↑
Gap Down
DRRX
DURECT
1.3768 of 5 stars
$0.58
+1.0%
N/A-58.6%$17.94M$1.86M-0.9580Positive News
LGVN
Longeveron
3.5364 of 5 stars
$1.19
+0.8%
$8.67
+628.3%
+65.9%$17.62M$2.23M-0.1920News Coverage
Gap Down
LPCN
Lipocine
2.3318 of 5 stars
$3.20
flat
$9.00
+181.3%
-57.8%$17.12M$3.67M-4.2110Analyst Forecast
Analyst Revision
COCP
Cocrystal Pharma
2.6463 of 5 stars
$1.65
-1.8%
$7.00
+324.1%
-39.7%$17.09MN/A-0.8910Short Interest ↑
MRKR
Marker Therapeutics
4.2978 of 5 stars
$1.51
-0.7%
$13.17
+772.0%
-51.6%$17.09M$6.59M-1.1460Positive News
GOVX
GeoVax Labs
3.4559 of 5 stars
$1.12
+6.7%
$11.10
+891.1%
-26.5%$17.02M$5.59M-0.3110News Coverage

Related Companies and Tools


This page (NASDAQ:PLRZ) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners